Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

Articles published in
Cancer Res
    January 2025
  1. CHEN R, Ma C, Qian H, Xie X, et al
    Mutant KRAS and CK2 Cooperatively Stimulate SLC16A3 Activity to Drive Intrahepatic Cholangiocarcinoma Progression.
    Cancer Res. 2025 Jan 24. doi: 10.1158/0008-5472.CAN-24-2097.
    >> Share

  2. XIE P, Guo L, Yu Q, Zhao Y, et al
    ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis.
    Cancer Res. 2025;85:299-313.
    >> Share

  3. LUO YW, Fang Y, Zeng HX, Ji YC, et al
    HIF1alpha Counteracts TGFbeta1-Driven TSP1 Expression in Endothelial Cells to Stimulate Angiogenesis in the Hypoxic Tumor Microenvironment.
    Cancer Res. 2025;85:69-83.
    >> Share

    December 2024
  4. XUE S, Chen X, Qiu G, Liao H, et al
    CLK1 Activates YAP to Promote Intrahepatic Cholangiocarcinogenesis.
    Cancer Res. 2024 Dec 18. doi: 10.1158/0008-5472.CAN-24-0147.
    >> Share

  5. TURNHAM RE, Pitea A, Jang GM, Xu Z, et al
    HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma.
    Cancer Res. 2024 Dec 9. doi: 10.1158/0008-5472.CAN-24-0456.
    >> Share

  6. YANG Y, Luo J, Wang Z, Liu K, et al
    Energy Stress-induced CircEPB41(2) Promotes Lipogenesis in Hepatocellular Carcinoma.
    Cancer Res. 2024 Dec 5. doi: 10.1158/0008-5472.CAN-24-1630.
    >> Share

    November 2024
  7. ZHANG Q, Zhang Y, Fu C, He X, et al
    CSTF2 Supports Hypoxia Tolerance in Hepatocellular Carcinoma by Enabling m6A Modification Evasion of PGK1 to Enhance Glycolysis.
    Cancer Res. 2024 Nov 8. doi: 10.1158/0008-5472.CAN-24-2283.
    >> Share

    October 2024
  8. CUI Y, Chang Y, Ma X, Sun M, et al
    Ephrin A1 Stimulates CCL2 Secretion to Facilitate Pre-metastatic Niche Formation and Promote Gastric Cancer Liver Metastasis.
    Cancer Res. 2024 Oct 16. doi: 10.1158/0008-5472.CAN-24-1254.
    >> Share

    September 2024
  9. CONNER SJ, Borges HB, Guarin JR, Gerton TJ, et al
    Obesity Induces Temporally Regulated Alterations in the Extracellular Matrix That Drive Breast Tumor Invasion and Metastasis.
    Cancer Res. 2024;84:2761-2775.
    >> Share

  10. SHU Y, Jin X, Ji M, Zhang Z, et al
    Ku70 Binding to YAP Alters PARP1 Ubiquitination to Regulate Genome Stability and Tumorigenesis.
    Cancer Res. 2024;84:2836-2855.
    >> Share

  11. HOU PP, Zheng CM, Wu SH, Liu XX, et al
    Extracellular Vesicle-Packaged ACSL4 Induces Hepatocyte Senescence to Promote Hepatocellular Carcinoma Progression.
    Cancer Res. 2024 Sep 3. doi: 10.1158/0008-5472.CAN-24-0832.
    >> Share

    August 2024
  12. ZHANG S, Deshpande A, Verma BK, Wang H, et al
    Integration of Clinical Trial Spatial Multiomics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery.
    Cancer Res. 2024;84:2734-2748.
    >> Share

    July 2024
  13. LIAO S, Deng J, Deng M, Chen C, et al
    AFDN deficiency promotes liver tropism of metastatic colorectal cancer.
    Cancer Res. 2024 Jul 24. doi: 10.1158/0008-5472.CAN-23-3140.
    >> Share

    June 2024
  14. SHIRANI M, Levin S, Shebl B, Requena D, et al
    Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1.
    Cancer Res. 2024 Jun 18. doi: 10.1158/0008-5472.CAN-23-4110.
    >> Share

  15. LI L, Xie D, Yu S, Ma M, et al
    WNK1 Interaction with KEAP1 Promotes NRF2 Stabilization to Enhance the Oxidative Stress Response in Hepatocellular Carcinoma.
    Cancer Res. 2024 Jun 17. doi: 10.1158/0008-5472.CAN-23-1167.
    >> Share

    May 2024
  16. RETTIG AR, Ganesh K
    Cancer Cells Hijack Physiologic Metabolic Signals to Seed Liver Metastasis.
    Cancer Res. 2024;84:1548-1549.
    >> Share

  17. HE W, Wang M, Zhang X, Wang Y, et al
    Estrogen induces LCAT to maintain cholesterol homeostasis and suppress hepatocellular carcinoma development.
    Cancer Res. 2024 May 8. doi: 10.1158/0008-5472.CAN-23-3966.
    >> Share

  18. ZHANG R, Li S, Schippers K, Li Y, et al
    Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate beta-Catenin Signaling.
    Cancer Res. 2024;84:1443-1459.
    >> Share

    April 2024
  19. YANG S, Zhang D, Sun Q, Nie H, et al
    Single-Cell and Spatial Transcriptome Profiling Identifies the Transcription Factor BHLHE40 as a Driver of EMT in Metastatic Colorectal Cancer.
    Cancer Res. 2024 Apr 24. doi: 10.1158/0008-5472.CAN-23-3264.
    >> Share

    March 2024
  20. HUANG J, Tsang WY, Fang XN, Zhang Y, et al
    FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma.
    Cancer Res. 2024;84:855-871.
    >> Share

  21. WENG J, Wang Z, Hu Z, Xu W, et al
    Repolarization of immunosuppressive macrophages by targeting SLAMF7-regulated CCL2 signaling sensitizes hepatocellular carcinoma to immunotherapy.
    Cancer Res. 2024 Mar 14. doi: 10.1158/0008-5472.CAN-23-3106.
    >> Share

  22. LIAO H, Chen X, Wang H, Lin Y, et al
    Whole-genome DNA methylation profiling of intrahepatic cholangiocarcinoma reveals prognostic subtypes with distinct biological drivers.
    Cancer Res. 2024 Mar 12. doi: 10.1158/0008-5472.CAN-23-3298.
    >> Share

  23. WAN S, He QY, Yang Y, Liu F, et al
    SPARC stabilizes ApoE to induce cholesterol-dependent invasion and sorafenib resistance in hepatocellular carcinoma.
    Cancer Res. 2024 Mar 12. doi: 10.1158/0008-5472.CAN-23-2889.
    >> Share

    February 2024
  24. WANG Y, Cheng C, Lu Y, Lian Z, et al
    beta-catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma.
    Cancer Res. 2024 Feb 28. doi: 10.1158/0008-5472.CAN-23-0673.
    >> Share

  25. SONG M, Zhang C, Cheng S, Ouyang D, et al
    DNA of neutrophil extracellular traps binds TMCO6 to impair CD8+ T-cell immunity in hepatocellular carcinoma.
    Cancer Res. 2024 Feb 21. doi: 10.1158/0008-5472.CAN-23-2986.
    >> Share

  26. LIU X, Wang X, Yang Q, Luo L, et al
    Th17 cells secrete TWEAK to trigger epithelial-mesenchymal transition and promote colorectal cancer liver metastasis.
    Cancer Res. 2024 Feb 9. doi: 10.1158/0008-5472.CAN-23-2123.
    >> Share

    January 2024
  27. ZHANG X, Su T, Wu Y, Cai Y, et al
    N6-methyladenosine reader YTHDF1 promotes stemness and therapeutic resistance in hepatocellular carcinoma by enhancing NOTCH1 expression.
    Cancer Res. 2024 Jan 19. doi: 10.1158/0008-5472.CAN-23-1916.
    >> Share

  28. MU M, Huang CX, Qu C, Li PL, et al
    Targeting ferroptosis-elicited inflammation suppresses hepatocellular carcinoma metastasis and enhances sorafenib efficacy.
    Cancer Res. 2024 Jan 17. doi: 10.1158/0008-5472.CAN-23-1796.
    >> Share

    December 2023
  29. DATTA J, Kutay H, Nasser MW, Nuovo GJ, et al
    Retraction: Methylation Mediated Silencing of MicroRNA-1 Gene and Its Role in Hepatocellular Carcinogenesis.
    Cancer Res. 2023;83:4181.
    >> Share

  30. MAJUMDER S, Roy S, Kaffenberger T, Wang B, et al
    Retraction: Loss of Metallothionein Predisposes Mice to Diethylnitrosamine-Induced Hepatocarcinogenesis by Activating NF-kappaB Target Genes.
    Cancer Res. 2023;83:4179.
    >> Share

    November 2023
  31. ZHUANG Q, Dai Z, Xu X, Bai S, et al
    RNA methyltransferase FTSJ3 regulates the type I interferon pathway to promote hepatocellular carcinoma immune evasion.
    Cancer Res. 2023 Nov 14. doi: 10.1158/0008-5472.CAN-23-2049.
    >> Share

  32. CHEN Z, Zhang G, Ren X, Yao Z, et al
    Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer.
    Cancer Res. 2023;83:3544-3561.
    >> Share

    September 2023
  33. SU T, Zhang N, Wang T, Zeng J, et al
    Super enhancer-regulated lncRNA LINC01089 induces alternative splicing of DIAPH3 to drive hepatocellular carcinoma metastasis.
    Cancer Res. 2023 Sep 26. doi: 10.1158/0008-5472.CAN-23-0544.
    >> Share

  34. HUNG MH, Wang XW
    Targeting WNT/beta-catenin via modulating EZH2 function - a new chapter in the treatment of beta-catenin mutant hepatocellular carcinoma?
    Cancer Res. 2023 Sep 25. doi: 10.1158/0008-5472.CAN-23-2921.
    >> Share

    August 2023
  35. ZHENG Y, Zhou R, Cai J, Yang N, et al
    Matrix stiffness triggers lipid metabolic crosstalk between tumor and stromal cells to mediate bevacizumab resistance in colorectal cancer liver metastases.
    Cancer Res. 2023 Aug 23:CAN-23-0025. doi: 10.1158/0008-5472.CAN-23-0025.
    >> Share

    June 2023
  36. MATSUMOTO S, Harada A, Seta M, Akita M, et al
    Wnt Signaling Stimulates Cooperation between GREB1 and HNF4alpha to Promote Proliferation in Hepatocellular Carcinoma.
    Cancer Res. 2023 Jun 22:OF1-OF16. doi: 10.1158/0008-5472.CAN-22-3518.
    >> Share

  37. ZHANG Q, Wei T, Yan L, Zhu S, et al
    Hypoxia-responsive lncRNA AC115619 encodes a micropeptide that suppresses m6A modifications and hepatocellular carcinoma progression.
    Cancer Res. 2023 Jun 16:CAN-23-0337. doi: 10.1158/0008-5472.CAN-23-0337.
    >> Share

  38. SCHEPERS EJ, Glaser K, Zwolshen HM, Hartman SJ, et al
    Structural and Functional Impact of Posttranslational Modification of Glypican-3 on Liver Carcinogenesis.
    Cancer Res. 2023;83:1933-1940.
    >> Share

    May 2023
  39. BEI Y, He J, Dong X, Wang Y, et al
    Targeting CD44 variant 5 with an antibody-drug conjugate is an effective therapeutic strategy for intrahepatic cholangiocarcinoma.
    Cancer Res. 2023 May 19:CAN-23-0510. doi: 10.1158/0008-5472.CAN-23-0510.
    >> Share

  40. ZHOU Q, Li L, Sha F, Lei Y, et al
    PTTG1 reprograms asparagine metabolism to promote hepatocellular carcinoma progression.
    Cancer Res. 2023 May 9:CAN-22-3561. doi: 10.1158/0008-5472.CAN-22-3561.
    >> Share

  41. MUNSON PV, Adamik J, Hartmann FJ, Favaro PMB, et al
    Polyunsaturated Fatty Acid-Bound alpha-Fetoprotein Promotes Immune Suppression by Altering Human Dendritic Cell Metabolism.
    Cancer Res. 2023;83:1543-1557.
    >> Share

    April 2023
  42. WOOD CS, Pennel KAF, Leslie H, Legrini A, et al
    Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases.
    Cancer Res. 2023;83:1329-1344.
    >> Share

  43. FANG JH, Chen JY, Zheng JL, Zeng HX, et al
    Fructose Metabolism in Tumor Endothelial Cells Promotes Angiogenesis by Activating AMPK Signaling and Mitochondrial Respiration.
    Cancer Res. 2023;83:1249-1263.
    >> Share

    December 2022
  44. DHANASEKARAN R, Hansen AS, Park J, Lemaitre L, et al
    MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma that is Reversible Through Restoration of Pro-Inflammatory Macrophages.
    Cancer Res. 2022 Dec 16:CAN-22-0232. doi: 10.1158/0008-5472.CAN-22-0232.
    >> Share

  45. HAN J, Meng J, Chen S, Wang X, et al
    Correction: YY1 Complex Promotes Quaking Expression via Super-Enhancer Binding during EMT of Hepatocellular Carcinoma.
    Cancer Res. 2022;82:4694.
    >> Share

  46. CHENG X, Tan X, Wang W, Zhang Z, et al
    Long-chain acylcarnitines induce senescence of invariant natural killer T cells in hepatocellular carcinoma.
    Cancer Res. 2022 Dec 13:CAN-22-2273. doi: 10.1158/0008-5472.CAN-22-2273.
    >> Share

  47. TEIJEIRA A, Garasa S, Luri-Rey C, de Andrea C, et al
    Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy.
    Cancer Res. 2022;82:4373-4385.
    >> Share

    November 2022
  48. WUESTEFELD A, Iakovleva V, Yap SXL, Ong ABL, et al
    A pro-regenerative environment triggers premalignant to malignant transformation of senescent hepatocytes.
    Cancer Res. 2022 Nov 30:CAN-22-1477. doi: 10.1158/0008-5472.CAN-22-1477.
    >> Share

  49. ZHU X, Song G, Zhang S, Chen J, et al
    Asialoglycoprotein Receptor 1 Functions as a Tumor Suppressor in Liver Cancer via Inhibition of STAT3.
    Cancer Res. 2022;82:3987-4000.
    >> Share

    October 2022
  50. DUDA DG, Jain RK
    Revisiting Antiangiogenic Multikinase Inhibitors in the Era of Immune Checkpoint Blockade: The Case of Sorafenib.
    Cancer Res. 2022;82:3665-3667.
    >> Share

    September 2022
  51. XIAO Y, Li Y, Shi D, Wang X, et al
    MEX3C-mediated decay of SOCS3 mRNA promotes JAK2/STAT3 signaling to facilitate metastasis in hepatocellular carcinoma.
    Cancer Res. 2022 Sep 16. pii: 709244. doi: 10.1158/0008-5472.CAN-22-1203.
    >> Share

  52. MAN K, Pang L, Yeung OWH, Ng KTP, et al
    Postoperative plasmacytoid dendritic cells secrete IFN-alpha to promote recruitment of myeloid-derived suppressor cells and drive hepatocellular carcinoma recurrence.
    Cancer Res. 2022 Sep 14. pii: 709225. doi: 10.1158/0008-5472.CAN-22-1199.
    >> Share

  53. HUANG M, Long J, Yao Z, Zhao Y, et al
    METTL1-mediated m7G tRNA modification promotes lenvatinib resistance in hepatocellular carcinoma.
    Cancer Res. 2022 Sep 14. pii: 709196. doi: 10.1158/0008-5472.CAN-22-0963.
    >> Share

  54. HU B, Zou T, Qin W, Shen X, et al
    Inhibition of EGFR overcomes acquired lenvatinib resistance driven by STAT3-ABCB1 signaling in hepatocellular carcinoma.
    Cancer Res. 2022 Sep 6. pii: 708982. doi: 10.1158/0008-5472.CAN-21-4140.
    >> Share

    August 2022
  55. BARTON MC, Lozano G
    p53 Activation Paradoxically Causes Liver Cancer.
    Cancer Res. 2022;82:2824-2825.
    >> Share

    July 2022
  56. PRIVES C, Suzuki S, Venkatesh D, Kanda H, et al
    GLS2 is a tumor suppressor and a regulator of ferroptosis in hepatocellular carcinoma.
    Cancer Res. 2022 Jul 27. pii: 707287. doi: 10.1158/0008-5472.CAN-21-3914.
    >> Share

  57. LI Y, Li B, Xu Y, Qian L, et al
    GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors.
    Cancer Res. 2022 Jul 27. pii: 707288. doi: 10.1158/0008-5472.CAN-22-0042.
    >> Share

  58. WANG JC, Chen DP, Lu SX, Chen JB, et al
    PIM2 expression induced by proinflammatory macrophages suppresses immunotherapy efficacy in hepatocellular carcinoma.
    Cancer Res. 2022 Jul 11. pii: 706923. doi: 10.1158/0008-5472.CAN-21-3899.
    >> Share

  59. XIE C, Wang FY, Sang Y, Chen B, et al
    Mitochondrial Micropeptide STMP1 Enhances Mitochondrial Fission to Promote Tumor Metastasis.
    Cancer Res. 2022;82:2431-2443.
    >> Share

    June 2022
  60. MOK EH, Leung CO, Zhou L, Lei MML, et al
    Caspase-3-induced activation of SREBP2 drives drug resistance via promotion of cholesterol biosynthesis in hepatocellular carcinoma.
    Cancer Res. 2022 Jun 29. pii: 705310. doi: 10.1158/0008-5472.CAN-21-2934.
    >> Share

  61. SHAN H, Liu T, Gan H, He S, et al
    RNA helicase DDX24 stabilizes LAMB1 to promote hepatocellular carcinoma progression.
    Cancer Res. 2022 Jun 28. pii: 705275. doi: 10.1158/0008-5472.CAN-21-3748.
    >> Share

  62. MAKINO Y, Hikita H, Fukumoto K, Sung JH, et al
    Constitutive activation of the tumor suppressor p53 in hepatocytes paradoxically promotes non-cell autonomous liver carcinogenesis.
    Cancer Res. 2022 Jun 13. pii: 704882. doi: 10.1158/0008-5472.CAN-21-4390.
    >> Share

    May 2022
  63. HEINZ MC, Peters NA, Oost KC, Lindeboom RGH, et al
    Liver Colonization by Colorectal Cancer Metastases Requires YAP-Controlled Plasticity at the Micrometastatic Stage.
    Cancer Res. 2022;82:1953-1968.
    >> Share

  64. LIU Z, Ye Y, Liu Y, Liu Y, et al
    RNA Helicase DHX37 Facilitates Liver Cancer Progression by Cooperating with PLRG1 to Drive Superenhancer-Mediated Transcription of Cyclin D1.
    Cancer Res. 2022;82:1937-1952.
    >> Share

    April 2022
  65. CHENG Y, Bai F, Ren X, Sun R, et al
    Phosphoinositide-Binding Protein TIPE1 Promotes Alternative Activation of Macrophages and Tumor Progression via PIP3/Akt/TGFbeta Axis.
    Cancer Res. 2022;82:1603-1616.
    >> Share

  66. BAYARD Q, Cordier P, Peneau C, Imbeaud S, et al
    Structure, Dynamics, and Impact of Replication Stress-Induced Structural Variants in Hepatocellular Carcinoma.
    Cancer Res. 2022 Apr 8:OF1-OF12. doi: 10.1158/0008-5472.CAN-21-3665.
    >> Share

    January 2022
  67. LI J, Hu ZQ, Yu S, Mao L, et al
    CircRPN2 inhibits aerobic glycolysis and metastasis in hepatocellular carcinoma.
    Cancer Res. 2022 Jan 19. pii: 0008-5472.CAN-21-1259.
    >> Share

  68. ADACHI Y, Kamiyama H, Ichikawa K, Fukushima S, et al
    Inhibition of FGFR Reactivates IFNgamma Signaling in Tumor Cells to Enhance the Combined Antitumor Activity of Lenvatinib with Anti-PD-1 Antibodies.
    Cancer Res. 2022;82:292-306.
    >> Share

    December 2021
  69. MA WK, Voss DM, Scharner J, Costa ASH, et al
    ASO-based PKM splice-switching therapy inhibits hepatocellular carcinoma growth.
    Cancer Res. 2021 Dec 17. pii: 0008-5472.CAN-20-0948.
    >> Share

  70. CHEN Y, Ling Z, Cai X, Xu Y, et al
    Activation of YAP1 by N6-methyladenosine-modified CircCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
    Cancer Res. 2021 Dec 16. pii: 0008-5472.CAN-21-1628.
    >> Share

  71. XU F, Tong M, Tong CSW, Chan BKC, et al
    A Combinatorial CRISPR-Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment.
    Cancer Res. 2021;81:6219-6232.
    >> Share

  72. BELLIDO MOLIAS F, Sim A, Leong KW, An O, et al
    Antisense RNAs Influence Promoter Usage of Their Counterpart Sense Genes in Cancer.
    Cancer Res. 2021;81:5849-5861.
    >> Share

    November 2021
  73. PEASE DR, Fernandez-Zapico ME
    mTOR-Dependent ARID1A Degradation: A New Twist in the Genetic-Epigenetic Interplay Driving Hepatocellular Carcinoma.
    Cancer Res. 2021;81:5608-5610.
    >> Share

  74. REN X, Rong Z, Liu X, Gao J, et al
    The protein kinase activity of NME7 activates Wnt/beta-Catenin signaling to promote one-carbon metabolism in hepatocellular carcinoma.
    Cancer Res. 2021 Nov 11. pii: 0008-5472.CAN-21-1020.
    >> Share

  75. SENDI H, Yazdimamaghani M, Hu M, Sultanpuram N, et al
    Nanoparticle delivery of miR-122 inhibits colorectal cancer liver metastasis.
    Cancer Res. 2021 Nov 9. pii: 0008-5472.CAN-21-2269.
    >> Share

    October 2021
  76. BARCENA-VARELA M, Lujambio A
    A Novel Long Noncoding RNA Finetunes the DNA Damage Response in Hepatocellular Carcinoma.
    Cancer Res. 2021;81:4899-4900.
    >> Share

    September 2021
  77. LOH JJ, Li TW, Zhou L, Wong TL, et al
    FSTL1 secreted by activated fibroblasts promotes hepatocellular carcinoma metastasis and stemness.
    Cancer Res. 2021 Sep 22. pii: 0008-5472.CAN-20-4226.
    >> Share

  78. KAN X, Zhou G, Zhang F, Ji H, et al
    Interventional Optical Imaging Permits Instant Visualization of Pathological Zones of Ablated Tumor Periphery and Residual Tumor Detection.
    Cancer Res. 2021;81:4594-4602.
    >> Share

    August 2021
  79. ZHANG S, Zhou YF, Cao J, Burley SK, et al
    mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma.
    Cancer Res. 2021 Aug 24. pii: 0008-5472.CAN-21-0206.
    >> Share

    July 2021
  80. UNFRIED JP, Marin-Baquero M, Rivera-Calzada A, Razquin N, et al
    Long noncoding RNA NIHCOLE promotes ligation efficiency of DNA double-strand breaks in hepatocellular carcinoma.
    Cancer Res. 2021 Jul 28. pii: 0008-5472.CAN-21-0463.
    >> Share

  81. QIU X, Yang S, Wang S, Wu J, et al
    M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma.
    Cancer Res. 2021 Jul 23. pii: 0008-5472.CAN-21-0468.
    >> Share

  82. TANG M, Yang M, Wu G, Mo S, et al
    Epigenetic Induction of Mitochondrial Fission Is Required for Maintenance of Liver Cancer-Initiating Cells.
    Cancer Res. 2021;81:3835-3848.
    >> Share

  83. PARK M, Kim JW, Kim KM, Kang S, et al
    Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and Chemoresistance.
    Cancer Res. 2021;81:3539-3553.
    >> Share

    June 2021
  84. SHRIKI A, Lanton T, Sonnenblick A, Levkovitch-Siany O, et al
    Multiple Roles of IL-6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis.
    Cancer Res. 2021 Jun 11. pii: 0008-5472.CAN-21-0321.
    >> Share

  85. GONZALEZ-ROMERO F, Mestre D, Aurrekoetxea I, O'Rourke CJ, et al
    E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment.
    Cancer Res. 2021;81:2874-2887.
    >> Share

  86. LULLI M, Del Coco L, Mello T, Sukowati C, et al
    DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer.
    Cancer Res. 2021;81:2861-2873.
    >> Share

    May 2021
  87. ZHAO Z, Gad H, Benitez-Buelga C, Sanjiv K, et al
    NEIL3 prevents senescence in hepatocellular carcinoma by repairing oxidative lesions at telomeres during mitosis.
    Cancer Res. 2021 May 27. pii: 0008-5472.CAN-20-1028.
    >> Share

  88. MA APY, Yeung CLS, Tey SK, Mao X, et al
    Suppression of ACADM-mediated fatty acid oxidation promotes hepatocellular carcinoma via aberrant Cav1/SREBP-1 signaling.
    Cancer Res. 2021 May 11. pii: 0008-5472.CAN-20-3944.
    >> Share

    April 2021
  89. LEUNG HW, Leung CO, Lau EY, Chung KPS, et al
    EPHB2 activates beta-catenin to enhance cancer stem cell properties and drive sorafenib resistance in hepatocellular carcinoma.
    Cancer Res. 2021 Apr 26. pii: 0008-5472.CAN-21-0184.
    >> Share

  90. DU L, Li Y, Kang M, Feng M, et al
    USP48 is upregulated by Mettl14 to attenuate hepatocellular carcinoma via regulating SIRT6 stabilization.
    Cancer Res. 2021 Apr 26. pii: 0008-5472.CAN-20-4163.
    >> Share

  91. RICCIOTTI E, Wangensteen KJ, FitzGerald GA
    Aspirin in hepatocellular carcinoma.
    Cancer Res. 2021 Apr 23. pii: 0008-5472.CAN-21-0758.
    >> Share

  92. FUHRMAN BJ, Moore SC, Byrne C, Makhoul I, et al
    Association of the Age at Menarche with Site-Specific Cancer Risks in Pooled Data from Nine Cohorts.
    Cancer Res. 2021;81:2246-2255.
    >> Share

  93. BROADFIELD LA, Duarte JAG, Schmieder R, Broekaert D, et al
    Fat Induces Glucose Metabolism in Nontransformed Liver Cells and Promotes Liver Tumorigenesis.
    Cancer Res. 2021;81:1988-2001.
    >> Share

    February 2021
  94. ZHOU J, Li Q, Cao Y
    Spatiotemporal Heterogeneity Across Metastases and Organ-Specific Response Informs Drug Efficacy and Patient Survival in Colorectal Cancer.
    Cancer Res. 2021 Feb 15. pii: 0008-5472.CAN-20-3665.
    >> Share

  95. DAVENPORT ML, Echols JB, Silva AD, Anderson JC, et al
    miR-31 displays subtype specificity in lung cancer.
    Cancer Res. 2021 Feb 8. pii: 0008-5472.CAN-20-2769.
    >> Share

    January 2021
  96. YAMADA K, Oikawa T, Kizawa R, Motohashi S, et al
    Unconventional Secretion of PKCdelta Exerts Tumorigenic Function via Stimulation of ERK1/2 Signaling in Liver Cancer.
    Cancer Res. 2021;81:414-425.
    >> Share

  97. HONG SH, Son KH, Ha SY, Wee TI, et al
    Nucleoporin 210 Serves a Key Scaffold for SMARCB1 in Liver Cancer.
    Cancer Res. 2021;81:356-370.
    >> Share

  98. GENG Y, Fan J, Chen L, Zhang C, et al
    A Notch-Dependent Inflammatory Feedback Circuit between Macrophages and Cancer Cells Regulates Pancreatic Cancer Metastasis.
    Cancer Res. 2021;81:64-76.
    >> Share

  99. BATTISTELLI C, Garbo S, Riccioni V, Montaldo C, et al
    Design and Functional Validation of a Mutant Variant of the LncRNA HOTAIR to Counteract Snail Function in Epithelial-to-Mesenchymal Transition.
    Cancer Res. 2021;81:103-113.
    >> Share

    October 2020
  100. WILLS CA, Liu X, Chen L, Zhao Y, et al
    Chemotherapy-Induced Upregulation of Small Extracellular Vesicle-Associated PTX3 Accelerates Breast Cancer Metastasis.
    Cancer Res. 2020 Oct 28. pii: 0008-5472.CAN-20-1976.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016